329 related articles for article (PubMed ID: 26929182)
21. O-GlcNAcylation increases PYGL activity by promoting phosphorylation.
Chen YF; Zhu JJ; Li J; Ye XS
Glycobiology; 2022 Mar; 32(2):101-109. PubMed ID: 34939084
[TBL] [Abstract][Full Text] [Related]
22. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
[TBL] [Abstract][Full Text] [Related]
23. Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes.
Robinson KA; Ball LE; Buse MG
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E884-90. PubMed ID: 17122093
[TBL] [Abstract][Full Text] [Related]
24. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells.
Goldberg HJ; Whiteside CI; Hart GW; Fantus IG
Endocrinology; 2006 Jan; 147(1):222-31. PubMed ID: 16365142
[TBL] [Abstract][Full Text] [Related]
25. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
26. Fetal Reprogramming of Nutrient Surplus Signaling, O-GlcNAcylation, and the Evolution of CKD.
Packer M
J Am Soc Nephrol; 2023 Sep; 34(9):1480-1491. PubMed ID: 37340541
[TBL] [Abstract][Full Text] [Related]
27. Lipopolysaccharide Induces GFAT2 Expression to Promote
Al-Mukh H; Baudoin L; Bouaboud A; Sanchez-Salgado JL; Maraqa N; Khair M; Pagesy P; Bismuth G; Niedergang F; Issad T
J Immunol; 2020 Nov; 205(9):2499-2510. PubMed ID: 32978282
[TBL] [Abstract][Full Text] [Related]
28. Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease.
Lefebvre T; Dehennaut V; Guinez C; Olivier S; Drougat L; Mir AM; Mortuaire M; Vercoutter-Edouart AS; Michalski JC
Biochim Biophys Acta; 2010 Feb; 1800(2):67-79. PubMed ID: 19732809
[TBL] [Abstract][Full Text] [Related]
29. O-GlcNAc signalling: implications for cancer cell biology.
Slawson C; Hart GW
Nat Rev Cancer; 2011 Aug; 11(9):678-84. PubMed ID: 21850036
[TBL] [Abstract][Full Text] [Related]
30. Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells.
Contador D; Ezquer F; Espinosa M; Arango-Rodriguez M; Puebla C; Sobrevia L; Conget P
Exp Biol Med (Maywood); 2015 Sep; 240(9):1235-46. PubMed ID: 25595190
[TBL] [Abstract][Full Text] [Related]
31. Activation of PPARgamma negatively regulates O-GlcNAcylation of Sp1.
Chung SS; Kim JH; Park HS; Choi HH; Lee KW; Cho YM; Lee HK; Park KS
Biochem Biophys Res Commun; 2008 Aug; 372(4):713-8. PubMed ID: 18513490
[TBL] [Abstract][Full Text] [Related]
32. Elevated O-GlcNAcylation stabilizes FOXM1 by its reduced degradation through GSK-3β inactivation in a human gastric carcinoma cell line, MKN45 cells.
Inoue Y; Moriwaki K; Ueda Y; Takeuchi T; Higuchi K; Asahi M
Biochem Biophys Res Commun; 2018 Jan; 495(2):1681-1687. PubMed ID: 29196265
[TBL] [Abstract][Full Text] [Related]
33. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy.
Swamy M; Pathak S; Grzes KM; Damerow S; Sinclair LV; van Aalten DM; Cantrell DA
Nat Immunol; 2016 Jun; 17(6):712-20. PubMed ID: 27111141
[TBL] [Abstract][Full Text] [Related]
34. miR-223 Regulates Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells Through a C/EBPs/miR-223/FGFR2 Regulatory Feedback Loop.
Guan X; Gao Y; Zhou J; Wang J; Zheng F; Guo F; Chang A; Li X; Wang B
Stem Cells; 2015 May; 33(5):1589-600. PubMed ID: 25641499
[TBL] [Abstract][Full Text] [Related]
35. 4-Hydroxyderricin and xanthoangelol from Ashitaba (Angelica keiskei) suppress differentiation of preadiopocytes to adipocytes via AMPK and MAPK pathways.
Zhang T; Sawada K; Yamamoto N; Ashida H
Mol Nutr Food Res; 2013 Oct; 57(10):1729-40. PubMed ID: 23681764
[TBL] [Abstract][Full Text] [Related]
36. Elevation of O-GlcNAc and GFAT expression by nicotine exposure promotes epithelial-mesenchymal transition and invasion in breast cancer cells.
Zhang N; Zhu T; Yu K; Shi M; Wang X; Wang L; Huang T; Li W; Liu Y; Zhang J
Cell Death Dis; 2019 Apr; 10(5):343. PubMed ID: 31019204
[TBL] [Abstract][Full Text] [Related]
37. Transcription factor Nrf1 is negatively regulated by its O-GlcNAcylation status.
Chen J; Liu X; Lü F; Liu X; Ru Y; Ren Y; Yao L; Zhang Y
FEBS Lett; 2015 Aug; 589(18):2347-58. PubMed ID: 26231763
[TBL] [Abstract][Full Text] [Related]
38. Intracellular and extracellular O-linked N-acetylglucosamine in the nervous system.
Ogawa M; Sawaguchi S; Kamemura K; Okajima T
Exp Neurol; 2015 Dec; 274(Pt B):166-74. PubMed ID: 26278182
[TBL] [Abstract][Full Text] [Related]
39. The sweet side of AMPK signaling: regulation of GFAT1.
Scott JW; Oakhill JS
Biochem J; 2017 Mar; 474(7):1289-1292. PubMed ID: 28336748
[TBL] [Abstract][Full Text] [Related]
40. O-GlcNAc protein modification in cancer cells increases in response to glucose deprivation through glycogen degradation.
Kang JG; Park SY; Ji S; Jang I; Park S; Kim HS; Kim SM; Yook JI; Park YI; Roth J; Cho JW
J Biol Chem; 2009 Dec; 284(50):34777-84. PubMed ID: 19833729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
